journal article·2020-07-15Open access

Antibody Targeted Metal–Organic Frameworks for Bioimaging Applications

Kimberly S. Butler, Charles J. Pearce, Elizabeth A. Nail, Grace A. Vincent, Dorina F. Sava Gallis

ACS Applied Materials & Interfaces· Volume 12· Issue 28

Abstract

We report on the availability and chemical utility of primary amines within metal-organic frameworks (MOFs) for cell targeting. Primary amine groups represent one of the most versatile chemical moieties for conjugation to biologically relevant molecules, including antibodies and enzymes. Specifically, we used two different chemical conjugations schemes, utilizing the amino functionality on the organic linker: first, carbodiimide chemistry was used to link the primary amine to available carboxyl groups on the protein neutravidin; second, sulfhydryl cross-linking chemistry was used via Traut's reagent scheme. Importantly, this is the first report that documents this methodology implemented with MOF systems. Finally, the ability of the EpCAM antibody targeted MOFs to bind to a human epithelial cell line (A549), a common target for imaging studies, was confirmed with confocal microscopy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Dendrimers and Hyperbranched Polymers · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular and Microbiology Department, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States

Nanoscale Sciences Department, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States

Funding

Sandia National Laboratories

References (31)

Show source-provided references
1. 10.1021/ar200028a10.1021/ar200028a ↗
2. 10.1002/adma.20170763410.1002/adma.201707634 ↗
3. 10.1016/j.ccr.2017.08.01510.1016/j.ccr.2017.08.015 ↗
4. 10.1098/rsfs.2016.002710.1098/rsfs.2016.0027 ↗
5. 10.1371/journal.pone.018756310.1371/journal.pone.0187563 ↗
6. 10.1021/acsami.6b1157910.1021/acsami.6b11579 ↗
7. 10.1073/pnas.130591011010.1073/pnas.1305910110 ↗
8. 10.1021/ja906198y10.1021/ja906198y ↗
9. 10.1002/anie.20100827710.1002/anie.201008277 ↗
10. 10.1021/ja805884310.1021/ja8058843 ↗
11. 10.1039/C7DT02356A10.1039/C7DT02356A ↗
12. 10.1021/ja062744410.1021/ja0627444 ↗
13. Wang G. D. · Tomography · 2016 · 2 · 17910.18383/j.tom.2016.00226 ↗
14. 10.1039/C8CE00909K10.1039/C8CE00909K ↗
15. 10.1021/acsami.7b0585910.1021/acsami.7b05859 ↗
16. 10.1002/adma.20180020210.1002/adma.201800202 ↗
17. 10.1039/C8CS00014J10.1039/C8CS00014J ↗
18. 10.1016/j.xphs.2019.08.00910.1016/j.xphs.2019.08.009 ↗
19. Hermanson, G. T. In Bioconjugate Techniques, 3rd ed. Hermanson, G. T., Ed. 2013; Chapter 2, pp 127–228.10.1016/B978-0-12-382239-0.00002-9 ↗
20. 10.1021/acsami.8b2169810.1021/acsami.8b21698 ↗
21. 10.1021/cm900166h10.1021/cm900166h ↗
22. 10.2174/1573403X1066614091416055410.2174/1573403X10666140914160554 ↗
23. Park S. · Nat. Rev. Mater. · 2017 · 2 · 1710410.1038/natrevmats.2017.14 ↗
24. 10.1021/jm500410710.1021/jm5004107 ↗
25. 10.1039/C3TB20832J10.1039/C3TB20832J ↗
26. 10.1021/acs.analchem.5b0000110.1021/acs.analchem.5b00001 ↗
27. 10.1021/acs.chemmater.7b0326910.1021/acs.chemmater.7b03269 ↗
28. 10.1002/cplu.20120018610.1002/cplu.201200186 ↗
29. 10.1021/acs.langmuir.7b0206510.1021/acs.langmuir.7b02065 ↗
30. 10.1021/acsnano.6b0281910.1021/acsnano.6b02819 ↗
31. 10.1021/acs.chemmater.7b0312810.1021/acs.chemmater.7b03128 ↗